QUOTE AND NEWS
newratings.com  Nov 23  Comment 
BRUSSELS (dpa-AFX) - The Swiss stock market ended Wednesday's session with a modest increase. The market had slipped into the red after the first few hours of trade, but managed to break back into positive territory late in the afternoon. The...
Benzinga  Nov 22  Comment 
  Patterson Companies, Inc. (NASDAQ: PDCO) shares reached a new 52-week low of $37.92 on downbeat Q2 results. RiceBran Technologies (NASDAQ: RIBT) shares touched a new 52-week low of $0.990. RiceBran Technologies shares have declined...
Forbes  Nov 22  Comment 
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative...
newratings.com  Nov 21  Comment 
BRUSSELS (dpa-AFX) - The Swiss stock market ended the first session of the new trading week with a loss, adding to the losses of the previous session. The market declined in early trade and settled into a sideways trend for most of the day. The...
GenEng News  Nov 21  Comment 
Novartis has acquired Selexys Pharmaceuticals, an Oklahoma City based company specializing in hematologic and inflammatory disorders, for up to $665 million. Novartis acquired the company following receipt of results from the SUSTAIN...
newratings.com  Nov 21  Comment 
Novartis commends publication of major report which recommends broad use of dual bronchodilators to treat COPD Novartis International AG / Novartis commends publication of major report which recommends broad use of dual bronchodilators to treat...
Motley Fool  Nov 18  Comment 
Which of these two beaten-down drug stocks is better poised for a rebound: Regeneron or Novartis?
Reuters  Nov 18  Comment 
Novartis has abandoned a 2016 goal to start testing its autofocus contact lens on people, though it said the groundbreaking product it is making with internet giant Google is "progressing steadily."




 

Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki